AAREYDRUGS NSE filing

Newspaper Publication of Notice of 35th AGM

The RealCase readLow impact Neutral

Why it matters

This is a standard compliance announcement and has minimal impact on the company's operations or stock price.

The market read

The announcement is a routine disclosure about the publication of the AGM notice.

* Aarey Drugs & Pharmaceuticals Limited has announced the newspaper publication of the notice for its 35th Annual General Meeting (AGM). * The AGM will be conducted on 29th September 2025. * The notice was published in Active Times and Mumbai Lakshadeep newspapers on 10th September 2025.

Filing to action

What to do with a filing like this

Aarey Drugs & Pharmaceuticals Limited filed this with the NSE as a statutory disclosure, categorised under agm-egm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Aarey Drugs & Pharmaceuticals Limited. Read the original for the full detail.

View original filing